| 000 | 01865 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515004351.0 | ||
| 264 | 0 | _c20060407 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a1043-4666 | ||
| 024 | 7 |
_a10.1016/j.cyto.2005.09.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGao, Qin | |
| 245 | 0 | 0 |
_aThe mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha. _h[electronic resource] |
| 260 |
_bCytokine _cDec 2005 |
||
| 300 |
_a199-205 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtractyloside _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Circulation _xphysiology |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIon Channels _xdrug effects |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xbiosynthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitochondria, Heart _xdrug effects |
| 650 | 0 | 4 | _aMitochondrial Membrane Transport Proteins |
| 650 | 0 | 4 | _aMitochondrial Permeability Transition Pore |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocardial Infarction _xprevention & control |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xprevention & control |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aPotassium Channels, Calcium-Activated _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aZhang, Shi-Zhong | |
| 700 | 1 | _aCao, Chun-Mei | |
| 700 | 1 | _aBruce, Iain C | |
| 700 | 1 | _aXia, Qiang | |
| 773 | 0 |
_tCytokine _gvol. 32 _gno. 5 _gp. 199-205 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cyto.2005.09.008 _zAvailable from publisher's website |
| 999 |
_c15886869 _d15886869 |
||